Objective: Protein kinase C (PKC) activation impairs contractility in the normal heart but is protective during myocardial ischemia. We hypothesized that PKC remains activated post-ischemia and modulates myocardial excitation-contraction coupling during early reperfusion. Methods: Langendorff-perfused rabbit hearts where subjected to 25 min unmodified ischemia and 30 min reperfusion. Total PKC activity was measured, and the intracellular translocation pattern of PKC-a, -d, -e, and -h assessed by immunohistochemistry and fractionated Western immunoblotting. The PKC-inhibitors chelerythrine and GF109203X were added during reperfusion and also given to non-ischemic hearts. Measurements included left ventricular function, intracellular calcium handling measured by Rhod-2 spectrofluorometry, myofibrillar calcium responsiveness in beating and tetanized hearts, and metabolic parameters. Results: Total PKC activity was increased at end-ischemia and remained elevated after 30 min of reperfusion. The translocation pattern indicated PKC-e as the main active isoform during reperfusion. Post-ischemic PKC inhibition affected mainly diastolic relaxation, with lesser effect on 
Introduction
during early reperfusion. There are alterations of cellular and subcellular ion currents, and myofibrillar responsive- 21 Myocardial stunning is defined as reversible contractile ness to Ca is depressed [2] [3] [4] . In addition to the dysfunction after a period of ischemia, but the cellular deleterious effects of ischemia itself, reperfusion injury mechanisms underlying the observed phenomena are not adds to the development of post-ischemic dysfunction. fully understood [1] . High-energy phosphates and intracelBoth oxygen free radical production and calcium influx lular pH normalize after several minutes, but intracellular contribute to reperfusion injury, but the role of regulatory 21 calcium [Ca ] and sodium homeostasis remain disturbed enzymes in contributing to or protecting from reperfusion i injury is less clearly defined. Protein kinase C (PKC) is expressed in cardiomyocytes and its various isoforms have been implicated in the by intravenous injection of ketamine (100 mg / kg), and regulation of intracellular ion concentrations and contracheparin (500 U / kg). The hearts were rapidly excised and tile protein calcium sensitivity. In the non-ischemic heart, placed in 48C cold buffer solution. After cannulation of the PKC activation has been shown to impair contractile aorta, the hearts were perfused retrograde in the Langen- 21 function by decreasing cytosolic [Ca ] and myofibrillar dorff mode at 80 mmHg constant perfusion pressure with i responsiveness to calcium [5, 6] . Activated PKC is able to modified Krebs-Henseleit (KH) buffer (115 mmol / l NaCl, regulate the activity of actomyosin MgATPase by phos-26 mmol / l NaHCO , 11 mmol / l glucose, 1.8 mmol / l 3 phorylating Troponin I (TnI) both in vitro and in vivo MgSO , 1.8 mmol / l KH PO , 4.7 mmol / l KCl, 1.25 4 2 4 [7] [8] [9] [10] . There is accumulating evidence that PKC plays a mmol / l CaCl , and 10 U / l insulin), that had been equili-2 crucial role during myocardial ischemia and reperfusion. brated with a 95% O / 5% CO gas mixture and passed 2 2 PKC is activated during ischemia and phosphorylates through a 0.2 mm nylon filter. The final buffer pH was 21 contractile and regulatory proteins as well as Ca chan-7.35-7.45, PO was 550-600 mmHg, and PCO was 2 2 nels and proteins of the sarcoplasmic reticulum that are 30-40 mmHg. The temperature of the hearts was main- 21 important for maintaining intracellular Ca homeostasis tained at 378C and monitored with a thermistor probe and contractile efficiency [11] . Pre-ischemic activation of placed in the right ventricle. The cava and pulmonary veins PKC improves post-ischemic myocardial function [12] [13] [14] , were sutured closed and the pulmonary artery cannulated and it has been shown that the beneficial effects of in order to obtain samples of venous effluent under myocardial preconditioning are mediated by PKC [15] [16] [17] .
anerobic conditions. A fluid-filled latex balloon connected Recently, it has been demonstrated that hearts from to a micromanometry catheter (Millar Instruments, Houstransgenic mice chronically expressing activated PKC-b ton, TX) was placed in the left ventricle via the left atrium. are less susceptible to ischemia / reperfusion injury [18] .
The catheter was sutured to the mitral valve annulus and However, it remains unclear whether PKC activation the balloon kept in place by a thread attached to the tip, exerts its beneficial effects during the ischemic period or guided through the apex of the left ventricle and secured rather during post-ischemic reperfusion by improving with an external stopper. All hearts were paced at 180 energy metabolism, restoring calcium homeostasis, or beats / min via epicardial electrodes sutured to the right altering contractile protein response to cytosolic calcium.
ventricle. To facilitate pacing, the AV-node was crushed Studies of the role of PKC in the ischemic myocardium with a ligature placed at the apex of the triangle of Koch. usually activate or inhibit PKC prior to the onset of After 30 min stabilization, the hearts were subjected to ischemia, so that the effects of PKC during ischemia and 25 min normothermic global ischemia in a heated chamber during reperfusion myocardium cannot be distinguished.
filled with humidified room air. At the onset of reperfuWe hypothesized that PKC remains activated during sion, two specific but structurally different PKC inhibitors reperfusion and regulates myocardial excitation-contrac-(chelerythrine 2 mmol / l and 5 mmol / l, and GF 109203X in the beating heart, the Ca concentration in the perfu-2.4. Calcium measurements sate was increased stepwise from 0.5 to 4.0 mmol / l.
Measurement of beat-to-beat intracellular calcium trans-2.5. Tetanized heart preparation ients was performed in intact perfused rabbit hearts as we have previously described and validated in detail [20] . 21 To assess myofibrillar responsiveness to Ca more After 15 min of post-ischemic reperfusion, the hearts were 21 directly, a separate group of control and inhibitor-treated loaded with the Ca -sensitive dye Rhod-2-AM (Molecuhearts loaded with rhod-2 were evaluated using steadylar Probes, Eugene, OR) by perfusion with the cell-perme- min (supernatant5unfractionated tissue extract). Cytosolic absorbance at the specific time-point or at the end of the extracts were stored at 2808C for later analysis. Protein samples of 30 mg each were separated by SDS-PAGE gel 2.9. Infarct size electrophoresis and transferred to nitrocellulose membranes. Coomassie Brilliant Blue R-250 staining of the Three separate sets of hearts (n54) were subjected to 25 gels confirmed equal protein loading. The membranes were min normothermic ischemia and reperfused with or withincubated with the following primary antibodies: antiout chelerythrine (5 mmol / l) or GF 109203X (1.3 mmol / mouse PKC-e, polyclonal (Upstate Biotechnology, Lake l). Coronary effluent was collected before the onset of Placid, NY), anti-rabbit PKC-a, monoclonal (Upstate), ischemia, after 30 s reperfusion, and then in 5-min anti-human PKC-h, polyclonal (Calbiochem, San Diego, intervals. Creatine kinase (CK) release from the heart was CA), and anti-human PKC-d, monoclonal (Gibco, quantified using Oliver and Rosalki's enzymatic assay Gaithersburg, MD), followed by incubation with horserad-(Sigma). After 60 min reperfusion 2-mm-thick slices of ish peroxidase-conjugated goat anti-rabbit or anti-mouse left ventricular myocardium were prepared and incubated IgG secondary antibody and detection using enhanced in 1% triphenyltetrazolium chloride (TTC) in phosphatechemiluminescence (Amersham Life Science, Arlington buffered saline at 378C for 20 min. The stained slices were Heights, IL). These four isoforms were chosen because placed on a flatbed scanner and electronic images obtained. they have previously been implicated in the regulation of
The area of TTC negative-stained infarct regions was calcium handling and / or contractility in rabbit hearts. measured using Scion image analysis software (Scion Corp.). Infarct size was quantified for each slide using the formula negative stained area / positive stained area3100, 2.7. Immunohistochemistry and confocal microscopy and the mean value of all slices obtained from one ventricle calculated. Myocardial tissue samples were excised prior to ischemia, at end-ischemia, and following 30 min reperfu-2.10. Statistical analysis sion. Tissue was fixed in 2.5% paraformaldehyde overnight then paraffin-embedded and cut into 5 mm sections.
Analysis of calcium recordings was performed using Following de-paraffinization in xylene, slides containing Sigma Plot software (version 4.0, SPSS Inc., Chicago, IL). tissue sections were rehydrated through a graded ethanol Data are expressed as the mean6S.E.M. and statistical series and used immediately for immunostaining. The analysis performed using the SPSS software package sections were incubated with PKC antibodies (see above) (version 9.0, SPSS Inc., Chicago, IL). Differences between diluted 1:100 in 5% fetal bovine serum in PBS pH 7.4. the groups were tested for significance by one-way Primary antibodies were detected with an anti-mouse ANOVA using the Bonferroni correction for multiple Alexa 568E-conjugated secondary antibody (Molecular comparisons. If normal distribution and equal variance Probes). Coverslips were applied to the sections with testing was passed, Student's t-test was used to compare fluorescent mounting medium (Dako). Slides were visualindividual data sets. A two-tailed P value of less than 0.05 ized using a BioRad MRC 1024 Scanning Laser Confocal was considered statistically significant throughout. Microscope with a Nikon 633 oil immersion objective, NA5160 / 0.17. Alexa 568E was excited at 568 nm and fluorescence was detected between 589 and 621 nm.
3. Results Optical sectioning was performed at 0.5 mm increments and images were processed using the accompanying 3.1. PKC activity and translocation during reperfusion BioRad software.
PKC activity in whole-cell extracts was significantly 2.8. PKC activity increased at the end of the 25 min ischemic period and remained elevated at 30 min reperfusion (Fig. 1A) . Protein Total PKC-activity was measured in unfractionated content and subcellular distribution of four PKC isoforms tissue extracts (see above) using the SignaTECT Protein as determined by Western immunoblotting with subcellular Kinase C assay kit (Promega, Madison, WI). After purififractionation of left ventricular tissue are shown in Fig. 1B . cation of the enzyme by chromatography (DEAE cellulose
The distribution of potentially important PKC target column), the samples were incubated in the presence of 1.2 proteins in the fractionated samples is shown in the insert. 32 mM calcium, 0.5 mM (g P)ATP, 1.6 mg / ml phospha-LDH activity was only detected in the soluble fraction, tidylserine and 0.16 mg / ml diacylglycerol. Control reindicating that the particulate fraction contained no signifiactions were run in the absence of phospholipids. The cant amount of soluble cytosolic proteins. Troponin I was 32 1 1 (g P)-ATP transfer to the PKC-specific biotinylated pepdetected only in the cytosolic fraction, and Na / K tide substrate AAKIQAS*FRGHMARKK was then quanATPase protein as well as SERCA2 ATPase proteins were tified by absorption to a streptavidin matrix capture detected in the particulate fraction. Pre-ischemia, PKC-e membrane. PKC activity is expressed as pmol ATP was found mainly in the cytosolic fraction. At the end of transfer / min / mg protein.
the ischemic period, PKC-e translocated to the particulate (A) PKC activity in tissue extracts from control hearts and hearts subjected to 25 min ischemia (end-ischemia) followed by 30 min reperfusion (reperfusion). PKC activity is increased at end-ischemia and remains elevated during reperfusion. Both PKC inhibitors (chelerythrine and GF109203X) given during reperfusion effectively suppressed PKC activity. (B) Representative immunoblots of cytosolic and membranous fractions demonstrating the subcellular distribution of PKC-a, -d, -e, and -h in control hearts (pre-ischemia), after 25 min ischemia (end-ischemia), and after 30 min reperfusion (reperfusion). The insert shows the distribution of troponin I, Na1 /K1 ATPase, SERCA2 ATPase, and LDH activity in the fractionated samples. C, cytosolic fraction; P, particulate fraction.
fraction and remained there by 30 min reperfusion. PKC-a 3.2. PKC inhibition in non-ischemic hearts was found in both fractions pre-ischemia and at 30 min reperfusion. However, at end-ischemia PKC-a was only
Neither treatment with chelerythrine nor with detected in the cytosolic fraction. Both PKC-d and PKC-h GF109203X significantly altered left ventricular contracwere mainly detected in the cytosolic fraction pre-istility, relaxation, coronary flow, or myocardial oxygen chemia, and translocated to the particulate fraction during consumption in non-ischemic hearts ( Confocal microscopy of immunostained tissue sections removal were unchanged after treatment with both lower confirmed the translocation pattern seen by Western imand higher concentrations of chelerythrine and munoblotting. Fig. 2 demonstrates diffuse (cytosolic) stain-GF109203X (Table 2 ). The steady-state responsiveness of ing for PKC-e pre-ischemia. At end-ischemia, the PKC-emyofibrils to calcium as assessed in tetanized hearts were specific antibody localized predominantly in the plasalso not affected by inhibition of PKC in non-ischemic malemma, and at 30 min reperfusion there was some hearts ( Table 2) . redistribution of PKC-e to intracellular organelles, resulting in a more patchy fluorescence pattern. The subcel-3.3. PKC inhibition in post-ischemic hearts lular distribution of PKC-a, -d, and -h at 30 min reperfusion was not visibly different from pre-ischemia (images Both inhibitors significantly decreased PKC activity not shown).
during reperfusion compared to untreated controls (Fig . Fig. 2 . Confocal photomicrographs of rabbit ventricular myocardium stained for PKC-e. Tissue was paraffin-embedded, sectioned, and used for immunohistochemistry with an anti-mouse PKC-e polyclonal antibody. Primary antibody was detected with an Alexa568-conjugated secondary antibody.
(A) End-ischemic control stained with a non-specific primary antibody; (B-D) representative PKC-e staining in hearts subjected to no ischemia (B), at end-ischemia (C), and following 30 min reperfusion (D), respectively. The micrographs represent 0.5 mm optical sections of tissue that was aligned in the longitudinal orientation. Scale bars510 mm.
1A). Pre-ischemic contractile function measurements were ing energetic inefficiency ('oxygen wasting'). Data after not different from control (diastolic pressure5660.3 treatment with PKC inhibitors of non-ischemic and postmmHg; developed pressure511264 mmHg; coronary ischemic hearts are summarized in Table 1 . Three minutes flow55764 ml / min; MvO 50.8460.05 ml / min / g dry after the onset of reperfusion, there was no difference 2 weight). Post-ischemic control hearts showed the features between the groups in terms of systolic and diastolic of myocardial dysfunction with elevated diastolic pressure, pressure. However, after 30 min reperfusion with lower developed pressure (recovery of developed pressure chelerythrine or GF 109203X, relaxation was significantly in post-ischemic control hearts was 7464% at 30 min impaired as indicated by increased diastolic pressures and reperfusion), reduced 1dp /dt and 2dp /dt, lower coronary reduced 2dp /dt. Systolic LV pressure was elevated in flow, but unchanged or only mildly reduced MvO indicathearts treated with 0.2 mmol / l GF109203X but unchanged in all other groups, as was 1dp /dt. Developed pressure significantly (8.264, 7.165, 6.964 and 7.867 mmol / g (LV systolic2LV diastolic pressure) was consistently lower dry weight, with chelerythrine 2 and 5 mmol / l, and in post-ischemic hearts treated with either of the two PKC GF109203X 0.2 and 1.3 mmol / l, respectively). inhibitors (Fig. 3) . PKC inhibition in post-ischemic hearts Cytosolic calcium levels in beating hearts and tetanized did not affect coronary flow or myocardial oxygen conpreparations are summarized in hearts treated with PKC inhibitors, indicating increased myofibrillar responsiveness to cytosolic calcium (Fig. 5A) . However, the relationship between systolic calcium levels and developed pressure was essentially unchanged during reperfusion in the PKC inhibitor treated hearts (Fig. 5B ).
21
The indicating an increase in Ca sensitivity of the contractile apparatus due to inhibition of post-ischemic PKC activity.
The calculated values for the Hill coefficient, also shown in Table 2 , were 3.6 for post-ischemic untreated hearts, and 4.24 or 4.84 in chelerythrine or GF109203X treated hearts.
Myocyte necrosis
The average infarct size in control hearts subjected to ischemia and reperfusion was 8.661.8%. Post-ischemic treatment with 5 mmol / l chelerythrine or 1.3 mmol / l 21 GF109203X had no significant impact on myocardial Hearts were tetanized at different extracellular Ca concentrations (here: 3 mmol / l). Time resolution of the recording is 2 ms, the signal then filtered with a lowpass filter (sampling interval 2 ms, half power point of filter 5 Hz).
the extend of cardiomyocyte necrosis. PKC inhibition by both chelerythrine and GF109203X given only during reperfusion, not during ischemia, resulted in significant impairment of myocardial relaxation and systolic contractile function. The changes in contractile function were 21 associated with changes in [Ca ] homeostasis: posti ischemic calcium overload was further aggravated, diastolic calcium removal was delayed, and the amplitude of calcium transients was smaller. In post-ischemic control function, calcium handling, or metabolic parameters in non-ischemic hearts. The established mechanism of PKC activation in the heart involves receptor-mediated activation of phos-4. Discussion phatidyl-inositol specific phospholipase C (PI-PLC), resulting in phosphoinositide turnover with production of The main findings of our study are that PKC remains diacylglycerol (DAG) and inositol triphosphate. DAG in 21 activated throughout early reperfusion and its inhibition turn activates PKC, requiring Ca as a cofactor for 21 aggravates myocardial reperfusion injury without affecting activation of Ca -dependent isoforms. Activation of PKC, as indicated by translocation from the cytosolic to the particulate fraction, has been shown to occur during ischemia [22] [23] [24] [25] . The mechanism and time-course of receptor-independent myocardial PKC activation during ischemia are less clearly defined [11, 26] . Several studies have demonstrated that an increase of extracellular or intracellular calcium induces PKC-mediated cardioadaptation to ischemic injury [15, 16, 27 ], and we have recently shown that PI-PLC activation is necessary for translocation of PKC-a and e during myocardial ischemia [12] . In the present study we assessed PKC activity in non-fractionated tissue extracts as well as the translocation pattern of several isoforms in fractionated tissue and using immunohistochemistry. Increased expression of PKC-d and -e has been shown during prolonged periods of of ischemia [26] , but less is known about the reperfusion period. Kawamura et al. previously demonstrated transient translocation of PKC-a and -z following ischemic preconditioning, and only the e-and d-isoforms remained translocated after 35 min reperfusion [25] . Of the four isoforms we studied, PKC-e was the only one that consistently remained translocated to the particulate fraction after 30 min reperfusion. This finding is consistent with other studies which have identified PKC-e as the isoform mediating ischemic myocardial preconditioning [28, 29] , a phenomenon that requires some form of sustained activation or translocation to bridge the gap between the preconditioning stimulus and the onset of the actual ischemia. [30] . Our laboratory previously coni firmed these findings for the isolated perfused rabbit heart [5] , and Gwathmey and Hajjar described impaired sarcop- 21 lasmic Ca release after PKC activation in human myocardial trabeculae [31] . PKC inhibition in non-is- 21 chemic myocytes was shown to increase the Ca transient amplitude [6] . Conversely, several groups have reported an increase in contractility following PKC activation and / or decrease in contractility following PKC inhibition in different non-ischemic myocardial preparations [32, 33] . In our experiments we chose inhibitor concentrations that had no significant effect on myocardial function or metabolism in non-ischemic hearts, but did have an effect in postischemic hearts. We based this on our hypothesis that activated PKC has a greater regulatory impact on excita- suggesting a beneficial effect of PKC inhibitors during as duration of ischemia are likely to influence the net effect prolonged ischemia [34] . Furthermore, several groups have on post-ischemic recovery. 21 found that chelerythrine given before the onset of a period Due to the importance of intracellular free Ca as the of unmodified ischemia had no significant impact on postmediator of contractile protein interaction, the relation 21 ischemic recovery [35] [36] [37] . However, the aforementioned between PKC and [Ca ] has been of great interest. In i experiments have in common that PKC was manipulated vitro experiments have shown that PKC activation inhibits 21 21 before the onset of ischemia, so that it is not possible to sarcolemmal L-type Ca channels and increases Ca distinguish effects occurring during ischemia from those uptake by the sarcoplasmic reticulum by phosphorylating during post-ischemic reperfusion. Similarly, experiments phospholamban [38, 39] . Hence, activation of PKC during 21 using transgenic mice with chronically activated PKC or ischemia may serve as a mechanism to reduce Ca mutant PKC-specific phosphorylation sites are not able to accumulation in the cytosol. This is indirectly supported by differentiate pre-ischemic from post-ischemic effects of our finding that inhibition of PKC during reperfusion Decreased calcium responsiveness of the contractile apparatus is commonly expected to exert a negative inotropic effect. However, there is accumulating evidence that attenuation of contractile protein calcium sensitivity has in fact beneficial effects on myocardial function, which may be of particular importance in the post-ischemic heart. 21 Decreased Ca responsiveness of the myofilaments contributes to the increased relaxation rate of the beating heart under the influence of b-adrenergic stimulation through PKA-mediated phosphorylation of the myofibrillar troponin I (TnI) subunit, resulting in reduced affinity of 21 troponin C (TnC) for Ca . The role of PKC-mediated phosphorylation of contractile proteins is less clearly ATPase activity [7, 8, 10] , and reducing Ca sensitivity of the myofilaments [9] . However, in vivo, PKC phosphorylaother protein kinases are more than 100-fold higher than tion of contractile proteins and its functional consequences for PKC; thus we expect minimal effects on other sig- 21 have proven more difficult to demonstrate [40] . The Ca naling pathways at the low inhibitor concentrations used in responsiveness of myofibrils from stunned rabbit myocarthe present study. actomyosin MgATPase, the pCa of myofibrils, or the suppress PKC activity during a specific and limited time degree of phosphorylation of myofibrils from stunned and period following unmodified ischemia. We also confirmed non-stunned porcine myocardium [42] . Moreover, PKCthe effectiveness of the inhibitors by measuring PKC induced in vitro phosphorylation of myofibrils isolated activity. from non-stunned myocardium resulted in a leftward shift 21 21 of pCa , indicating an increase in Ca sensitivity. only during reperfusion after unmodified ischemia, we the beating heart. We also found an increase in myofibrillar observed impaired myocardial relaxation and contractility. 21 Ca responsiveness under the steady-state conditions of This was associated with higher intracellular free calcium the tetanized heart. It has been suggested that activation of levels, delayed diastolic calcium removal, and increased PKC in response to ischemia may be a signal for contracmyofibrillar responsiveness to calcium. In the post-istile quiescence and represents an energy-conserving dechemic heart, the increase in calcium responsiveness fense mechanism against ischemia [13] . However, there is results in impaired relaxation rather than improved systolic no difference in myocardial content of high-energy phosfunction. We conclude that PKC plays an important role in phates at end-ischemia following pre-ischemic activation the regulation of myocardial excitation-contraction couor inhibition of PKC [12] . Instead, we found evidence that pling during reperfusion. Hence, physiologic activation of PKC exerts much of its effects during reperfusion, when PKC during ischemia may serve a mechanism to restore contractility and relaxation have to be re-established in the and maintain cardiac function during reperfusion in the 21 presence of elevated [Ca ] . A recently evolved concept i presence of post-ischemic intracellular calcium overload. of myocardial stunning involves proteolytic breakdown of Furthermore, strategies to facilitate PKC activity postmyofibrillar proteins. Breakdown products of TnI and TnT ischemia may serve to treat myocardial stunning. have been identified in stunned myocardium [43, 44] , and McDonough et al. linked the TnI phosphorylation state with the rate of proteolytic breakdown [45] . This hypothAcknowledgements esis offers another explanation as to how post-ischemic PKC activation may affect myofibrillar integrity and This work was supported in part by NIH Grants HLfunction. PKC-mediated desensitization of myofibrils and 21 52589 (Francis X. McGowan) and HL-46207 (Pedro J. del improved diastolic Ca removal in the post-ischemic Nido). Christof Stamm was supported by a grant from the myocardium may serve to protect the heart from excessive 21 German Research Foundation (STA 497 / 2-1). rigor bond formation in the setting of elevated [Ca ] i post-ischemia. Additional evidence for the important role of PKC during reperfusion comes from a recent study using a novel pharmacologic PKC-activator (JTV519), References which improved post-ischemic function even when given during reperfusion only [46] . 
